OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
4.120
-0.090 (-2.14%)
Jul 16, 2026, 2:30 PM EDT - Market open
OnKure Therapeutics Employees
OnKure Therapeutics had 45 employees as of December 31, 2025. The number of employees decreased by 1 or -2.17% compared to the previous year.
Employees
45
Change (1Y)
-1
Growth (1Y)
-2.17%
Revenue / Employee
n/a
Profits / Employee
-$1,305,533
Market Cap
166.43M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 45 | -1 | -2.17% |
| Dec 31, 2024 | 46 | -3 | -6.12% |
| Jun 30, 2024 | 50 | - | - |
| Mar 31, 2024 | 49 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 164 |
| Tonix Pharmaceuticals Holding | 142 |
| Caribou Biosciences | 97 |
| Alpha Cognition | 71 |
| PepGen | 59 |
| Milestone Pharmaceuticals | 38 |
| Corbus Pharmaceuticals Holdings | 36 |
| Jyong Biotech | 27 |
OKUR News
- 1 day ago - OnKure Therapeutics Transcript: KOL event - Transcripts
- 1 day ago - OnKure Therapeutics Slides: KOL event - Filings
- 14 days ago - OnKure Therapeutics to Host Virtual KOL Event to Discuss PI3Kα Inhibitor Medicines: Selectivity Matters & Pan-Mutant Allosteric Inhibition Delivers, on July 15, 2026 - GlobeNewsWire
- 6 weeks ago - OnKure Therapeutics Transcript: AGM 2026 - Transcripts
- 2 months ago - OnKure Therapeutics downgraded to Hold from Buy at JonesResearch - TheFly
- 2 months ago - OnKure Therapeutics Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 2 months ago - OnKure Therapeutics Quarterly report: Q1 2026 - Filings
- 2 months ago - OnKure Therapeutics Earnings release: Q1 2026 - Filings